|NanoViricides, Inc. (NNVC)|
A typical nanoviricides drug is designed like a chemical missile. It has a number of recognition "ligands" on its surface, that are specific to a single type of virus, say HIV. They are like the GPS on a directed missile. They will identify the enemy and attach to specific "landing sites" on the enemy target. The nanoviricides drug, after landing, spreads itself all over the virus particle, and thus completely neutralizes and disables the virus particle from binding to its target, a human cell.
Market Cap: $263.38
Shares Outstanding: 42.76
Officers and Executives
Solubilization and Targeted Delivery of Drugs with Selfassembling Amphiphilic PolymersOral administration
Antibody response with Oral administration was stronger than that with IV administration.
Home Page: nanoviricides.com
Investor Relations: nanoviricides.com
Corporate History/Profile: nanoviricides.com
NanoViricides Inc Group Headquarters: SUITE 205, 135 WOOD STREET, WEST HAVEN, CT 06516, United States
Vecoy Nanomedicines Ltd.
Toxicology results due shortly.